Appointment booking for Dr. Camille Folkard, MD is currently not available.Dr. Camille Folkard, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Camille Folkard, MD (she/her) is an Endocrinologist, Internist in Texarkana, TX with over 10 years of experience. What is your opinion of Dr. Camille Folkard, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 10 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Camille Folkard, MD has received over $2,880 which includes payments from the following companies:
$636.47 from Merck Sharp & Dohme Corporation
$501.97 from Pfizer Inc.
$386.17 from E.R. Squibb & Sons, L.L.C.
$268.40 from AstraZeneca Pharmaceuticals LP
$218.90 from AbbVie, Inc.
$194.10 from LILLY USA, LLC
$163.44 from Novo Nordisk Inc
$134.09 from Edwards Lifesciences Corporation
$115.69 from sanofi-aventis U.S. LLC
$89.44 from Janssen Pharmaceuticals, Inc
$45.80 from Valeant Pharmaceuticals North America LLC
$37.65 from Shire North American Group Inc
$27.38 from The Medicines Company
$24.74 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$20.00 from Novartis Pharmaceuticals Corporation
$15.84 from Otsuka America Pharmaceutical, Inc.
Payments received by Dr. Camille Folkard, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!